Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Doshi

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
BMJ Evidence-Based Medicine|August 10, 2021
Transparency of COVID-19 vaccine trials: decisions without dataSarah Tanveer, Anisa Rowhani-Farid, Kyungwan Hong, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 6, 2013
Influenza vaccination of health care workersPeter Doshi, Elia Abi-Jaoude, Joel Lexchin, et al.
The Cochrane Database of Systematic Reviews|February 19, 2010
Neuraminidase inhibitors for preventing and treating influenza in healthy adultsTom Jefferson, Mark Jones, Peter Doshi, et al.
Health Affairs Scholar|December 8, 2025
Availability of consent forms in ClinicalTrials.gov for industry-sponsored trialsPeter Doshi, Jerry Menikoff, Robert Morlock, et al.
BMJ (Clinical Research Ed.)|February 9, 2017
Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agenciesAngela Spelsberg, Christof Prugger, Peter Doshi, et al.
BMJ (Clinical Research Ed.)|May 10, 2014
Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory commentsTom Jefferson, Mark Jones, Peter Doshi, et al.
Vaccine|June 18, 2023
Letter to the editorJoseph Fraiman, Juan Erviti, Mark Jones, et al.
Vaccine|September 2, 2022
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adultsJoseph Fraiman, Juan Erviti, Mark Jones, et al.
BMJ Evidence-Based Medicine|March 19, 2020
Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: restoration of previously unpublished methodologyPeter Doshi, Florence Bourgeois, Kyungwan Hong, et al.
Lancet (London, England)|October 7, 2014
Neuraminidase inhibitors for influenza complicationsChris Del Mar, Peter Doshi, Rokuro Hama, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
BMJ Evidence-Based Medicine|August 10, 2021
Transparency of COVID-19 vaccine trials: decisions without dataSarah Tanveer, Anisa Rowhani-Farid, Kyungwan Hong, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 6, 2013
Influenza vaccination of health care workersPeter Doshi, Elia Abi-Jaoude, Joel Lexchin, et al.
The Cochrane Database of Systematic Reviews|February 19, 2010
Neuraminidase inhibitors for preventing and treating influenza in healthy adultsTom Jefferson, Mark Jones, Peter Doshi, et al.
Health Affairs Scholar|December 8, 2025
Availability of consent forms in ClinicalTrials.gov for industry-sponsored trialsPeter Doshi, Jerry Menikoff, Robert Morlock, et al.
BMJ (Clinical Research Ed.)|February 9, 2017
Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agenciesAngela Spelsberg, Christof Prugger, Peter Doshi, et al.
BMJ (Clinical Research Ed.)|May 10, 2014
Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory commentsTom Jefferson, Mark Jones, Peter Doshi, et al.
Vaccine|June 18, 2023
Letter to the editorJoseph Fraiman, Juan Erviti, Mark Jones, et al.
Vaccine|September 2, 2022
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adultsJoseph Fraiman, Juan Erviti, Mark Jones, et al.
BMJ Evidence-Based Medicine|March 19, 2020
Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: restoration of previously unpublished methodologyPeter Doshi, Florence Bourgeois, Kyungwan Hong, et al.
Lancet (London, England)|October 7, 2014
Neuraminidase inhibitors for influenza complicationsChris Del Mar, Peter Doshi, Rokuro Hama, et al.
Pageof 15